. Author manuscript; available in PMC: 2017 Oct 15.

Published in final edited form as: Cancer. 2016 Jul 8;122(20):3215–3224. doi: 10.1002/cncr.30171

Table 3.

Frequency distributions for the four distress clusters in survivors

	Asymptomatic		Affective		Somatic		Comorbid
	n	%	n	%	n	%	n	%	p-value*
Total	9914	61.6	2229	13.9	2168	13.5	1722	10.7
Sex
Male	5461	65.8	1199	14.5	866	10.4	770	9.3	<0.0001
Female	4453	57.6	1030	13.3	1302	16.8	952	12.3	<0.0001
Race
White	8687	61.9	1972	14.1	1885	13.4	1485	10.6	0.0005
Black	618	63.6	107	11.0	156	16.0	91	9.4
Other	549	59.5	131	14.2	113	12.3	129	14.0
Education
<High school	598	49.7	202	16.8	189	15.7	214	17.8	<0.0001
High school	1930	62.2	388	12.5	405	13.1	378	12.2
Some college	3411	60.1	812	14.3	764	13.5	685	12.1
≥College graduate	3653	66.6	733	13.4	730	13.3	372	6.8
Marital Status
Single	4897	61.8	1300	16.4	904	11.4	826	10.4	<0.0001
Married/Live as married	4165	65	654	10.2	1022	16	562	8.8
Divorced/separated	629	49.5	220	17.3	163	12.8	259	20.4
Household Income
≤19,999	1067	48.2	364	16.4	342	15.4	441	19.9	<0.0001
20,000–39,999	1641	58.5	415	14.8	408	14.5	341	12.2
40,000–59,999	1670	61.4	380	14.0	386	14.2	283	10.4
60,000–79,999	1355	65.2	281	13.5	284	13.7	159	7.6
≥80,000	2749	69	495	12.4	474	11.9	268	6.7
Perceived Health Status
Excellent	2433	82.7	258	8.8	187	6.4	65	2.2	<0.0001
Very good	4138	69.9	811	13.7	645	10.9	323	5.5
Good	2725	53.3	845	16.5	865	16.9	680	13.3
Fair/Poor	551	28.4	303	15.6	449	23.2	636	32.8
Pain
Headache	2049	45.3	682	15.1	923	20.4	869	19.2	<0.0001
Other pain	356	39.6	138	15.4	220	24.5	185	20.6
No pain	7239	71.4	1338	13.2	958	9.4	603	5.9
Psychoactive Medication
Analgesics
Yes	759	40.9	289	15.6	399	21.5	411	22.1	<0.0001
No	9155	64.6	1940	13.7	1769	12.5	1311	9.2	<0.0001
Antidepressants
Yes	442	31.4	283	20.1	240	17.1	442	31.4	<0.0001
No	9472	64.8	1946	13.3	1928	13.2	1280	8.8	<0.0001
Anxiolytics, hypnotics, sedatives
Yes	199	28.8	98	14.2	156	22.5	239	34.5	<0.0001
No	9715	63.3	2131	13.9	2012	13.1	1483	9.7	<0.0001
CNS Stimulants
Yes	106	43.3	43	17.6	40	16.3	56	22.9	<0.0001
No	9808	62.1	2186	13.8	2128	13.5	1666	10.6	<0.0001
Neuroleptics
Yes	79	27.7	45	15.8	61	21.4	100	35.1	<0.0001
No	9835	62.5	2184	13.9	2107	13.4	1622	10.3	<0.0001
Muscle Relaxants
Yes	107	33.6	39	12.3	79	24.8	93	29.2	<0.0001
No	9807	62.4	2190	13.9	2089	13.3	1629	10.4	<0.0001
Diagnosis
Leukemia	2723	62.0	622	14.2	542	12.3	506	11.5	0.0021
CNS tumor	1614	60.9	412	15.5	328	12.4	298	11.2
Hodgkin lymphoma	1594	61.3	341	13.1	396	15.2	270	10.4
non-Hodgkin lymphoma	1013	63.6	219	13.7	204	12.8	158	9.9
Kidney (Wilms)	737	63.5	148	12.8	164	14.1	111	9.6
Neuroblastoma	472	62.5	105	13.9	116	15.4	62	8.2
Soft tissue sarcoma	765	63.1	164	13.5	162	13.4	121	10
Bone cancer	996	59.8	218	13.1	256	15.4	196	11.8
Diagnosis Decade
1970–79	3322	60.7	817	14.9	744	13.6	593	10.8	0.0095
1980–89	3306	62.4	753	14.2	700	13.2	538	10.2
1990–99	3286	62.5	659	12.5	723	13.7	591	11.2
Cancer Treatment
Antimetabolites
Yes	3669	60.9	857	14.2	798	13.2	700	11.6	0.1092
No	5168	61.3	1181	14.0	1191	14.1	887	10.5	0.1092
Anthracyclines
Yes	4142	62.0	830	12.4	928	13.9	776	11.6	<0.0001
No	4607	60.6	1182	15.5	1033	13.6	783	10.3	<0.0001
Alkylating Agents
Yes	4369	61.0	1003	14.0	990	13.8	796	11.1	0.4790
No	4120	62.0	941	14.2	874	13.2	707	10.6	0.4790
Steroids
Yes	4172	60.9	990	14.4	901	13.1	791	11.5	0.0485
No	4800	61.5	1085	13.9	1107	14.2	815	10.4	0.0485
Radiation
None	3807	63.0	813	13.5	772	12.8	650	10.8	<0.0001
Non-cranial	2622	60.0	595	13.6	682	15.6	474	10.8
Cranial	2332	60.1	612	15.8	491	12.7	446	11.5
Age and Time
	Mean	SD	Mean	SD	Mean	SD	Mean	SD	p-value
Age at baseline	27.1	5.9	26.5	5.8	27.6	6.0	27.3	5.9	<0.0001
Age at diagnosis	9.4	5.6	9.0	5.4	9.8	5.7	9.5	5.4	0.0001
Time since diagnosis	17.7	4.3	17.5	4.3	17.8	4.3	17.8	4.4	0.0633

Note. p-values based on chi-square tests for categorical and ANOVA for continuous variables; SD=standard deviation; Frequencies based on number of participants for whom information was available.